These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38693687)

  • 1. Prescription retinoid and contraception use in women in Australia: A population-based study.
    Gerhardy L; Nassar N; Litchfield M; Kennedy D; Smith A; Gillies MB; Pearson SA; Zoega H; Shand A
    Australas J Dermatol; 2024 Aug; 65(5):428-436. PubMed ID: 38693687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isotretinoin use and compliance with the Dutch Pregnancy Prevention Programme: a retrospective cohort study in females of reproductive age using pharmacy dispensing data.
    Teichert M; Visser LE; Dufour M; Rodenburg E; Straus SM; De Smet PA; Stricker BH
    Drug Saf; 2010 Apr; 33(4):315-26. PubMed ID: 20297863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent use of hormonal long-acting reversible contraception by women of reproductive age dispensed teratogenic medications, Australia, 2013-2021: a retrospective cohort study.
    Grzeskowiak LE; Moore V; Hall K; Ilomäki J; Schoenaker D; Lovegrove E; Mazza D; Black KI; Kennedy DS; Davies MJ; Rumbold A
    Med J Aust; 2024 Oct; 221(7):367-373. PubMed ID: 39285147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs associated with teratogenic mechanisms. Part I: dispensing rates among pregnant women in the Netherlands, 1998-2009.
    van Gelder MM; Bos JH; Roeleveld N; de Jong-van den Berg LT
    Hum Reprod; 2014 Jan; 29(1):161-7. PubMed ID: 24105826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in use of hormonal long-acting reversible contraceptive methods in Australia between 2006 and 2018: A population-based study.
    Grzeskowiak LE; Calabretto H; Amos N; Mazza D; Ilomaki J
    Aust N Z J Obstet Gynaecol; 2021 Feb; 61(1):128-134. PubMed ID: 33095452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysis.
    Durán CE; Riera-Arnau J; Abtahi S; Pajouheshnia R; Hoxhaj V; Gamba M; Alsina E; Martin-Perez M; Garcia-Poza P; Llorente-Garcia A; Gonzalez-Bermejo D; Ibánez L; Sabaté M; Vidal X; Ballarín E; Sanfélix-Gimeno G; Rodríguez-Bernal C; Peiró S; García-Sempere A; Sanchez-Saez F; Ientile V; Ingrasciotta Y; Guarneri C; Tanaglia M; Tari M; Herings R; Houben E; Swart-Polinder K; Holthuis E; Huerta C; Gini R; Roberto G; Bartolini C; Paoletti O; Limoncella G; Girardi A; Hyeraci G; Andersen M; Kristiansen SB; Hallgreen CE; Klungel O; Sturkenboom M
    Front Pharmacol; 2023; 14():1207976. PubMed ID: 37663263
    [No Abstract]   [Full Text] [Related]  

  • 7. Prescription opioid dispensing in Australian children and adolescents: a national population-based study.
    Bell J; Paget SP; Nielsen TC; Buckley NA; Collins J; Pearson SA; Nassar N
    Lancet Child Adolesc Health; 2019 Dec; 3(12):881-888. PubMed ID: 31604614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Claims for contraceptive services among young women filling chronic opioid prescriptions.
    Ray-Griffith SL; Chopra D; Stowe ZN; Martin BC
    Contraception; 2019 May; 99(5):296-299. PubMed ID: 30763579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in contraception and sterilization in Australia.
    Santow G
    Aust N Z J Obstet Gynaecol; 1991 Aug; 31(3):201-8. PubMed ID: 1804078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terminations of pregnancy for exposure to oral retinoids in South Australia, 1985-1993.
    Chan A; Keane RJ; Hanna M; Abbott M
    Aust N Z J Obstet Gynaecol; 1995 Nov; 35(4):422-6. PubMed ID: 8717569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoids and contraception.
    Ceyrac DL; Serfaty D; Lefrancq H
    Dermatology; 1992; 184(3):161-70. PubMed ID: 1392106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Documentation of contraception and pregnancy when prescribing potentially teratogenic medications for reproductive-age women.
    Schwarz EB; Postlethwaite DA; Hung YY; Armstrong MA
    Ann Intern Med; 2007 Sep; 147(6):370-6. PubMed ID: 17876020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Risk Medication Prescriptions in Primary Care for Women Without Documented Contraception.
    Panchal BD; Cash R; Moreno C; Vrontos E; Bourne C; Palmer S; Simpson A; Panchal AR
    J Am Board Fam Med; 2019; 32(4):474-480. PubMed ID: 31300567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Pharmacist Prescription With Dispensed Duration of Hormonal Contraception.
    Rodriguez MI; Edelman AB; Skye M; Anderson L; Darney BG
    JAMA Netw Open; 2020 May; 3(5):e205252. PubMed ID: 32432710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Prescribing Patterns Before and After Implementation of a National Policy to Reduce Inappropriate Alprazolam Prescribing in Australia.
    Schaffer AL; Buckley NA; Cairns R; Pearson S
    JAMA Netw Open; 2019 Sep; 2(9):e1911590. PubMed ID: 31532519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse Pregnancy and Child Outcomes in Oral Retinoid-Exposed Pregnancies: A Nationwide Population-Based Study.
    You W; Choi A; Lee H; Han JY; Lee JH; Shin JY
    J Korean Med Sci; 2024 Jul; 39(26):e201. PubMed ID: 38978488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Awareness of and Adherence to the Pregnancy Prevention Program for Oral Retinoids: A Questionnaire Survey in Denmark.
    Backran D; Ahmad S; Hansen JM; Almarsdóttir AB; Jacobsen R
    Pharmacoepidemiol Drug Saf; 2024 Oct; 33(10):e70023. PubMed ID: 39375989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Coronavirus disease 2019 (COVID-19) on contraception use in 2020 and up until the end of April 2021 in France.
    Roland N; Drouin J; Desplas D; Duranteau L; Cuenot F; Dray-Spira R; Weill A; Zureik M
    Contraception; 2022 Apr; 108():50-55. PubMed ID: 34971603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Provision of potentially teratogenic medications to female veterans of childbearing age.
    Schwarz EB; Longo LS; Zhao X; Stone RA; Cunningham F; Good CB
    Med Care; 2010 Sep; 48(9):834-42. PubMed ID: 20706159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teratogenic medications and concurrent contraceptive use in women of childbearing ability with epilepsy.
    Bhakta J; Bainbridge J; Borgelt L
    Epilepsy Behav; 2015 Nov; 52(Pt A):212-7. PubMed ID: 26460786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.